Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Integration – beyond the buzzword

What it should be and how it can work in practice

- PMLiVE

Regeneron drops RSV drug

Suptavumab failed to prevent the infections in re-term infants

- PMLiVE

Merck CEO resigns from Trump post in Charlottesville protest

Frazier leaves the Manufacturing Council but J&J’s Gorksy remains for now

- PMLiVE

Toward an outcome

Disrupting the product-centred development cycle

- PMLiVE

Hacking Innovation

RB’s Lions Health event saw teams compete to protect children in China from air pollution

- PMLiVE

Time running out on new Stada takeover bid

Only 34% of shareholders have backed the deal so far

- PMLiVE

Being social – harnessing the power of social media

With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

Porterhouse Medical Group

- PMLiVE

Ionis must go it alone as GSK ditches polyneuropathy drug

Inotersen’s side effects prompts pharma giant to relinquish rights

- PMLiVE

NICE expands Merck KGaA’s Erbitux reach

Backs the medicines use for patients with SCCHN

- PMLiVE

Righting pharma’s reputational wrongs

Addressing the issues of transparency in pharma

- PMLiVE

Ditch the data?

Looking beyond the data

Celgene building

Celgene steps back from $1bn Sutro acquisition

Instead opts for amended licensing deal with US biotech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links